Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Percentile
P33
Within normal range
vs 2Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
202562.71%
2024102.63%
2023391.80%
20220.00%